Recursion Pharmaceuticals Inc (RXRX)

Recursion Pharmaceuticals Inc Azioni (RXRX) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	26.66% 13.79	10.89	10.53	11.02	12.13
Cost Of Revenue	13.00% 11.17	9.881	10.88	9.382	12.45
Gross Profit	160.20% 2.628	1.01	-0.344	1.635	-0.314
Operating Expenses	0.97% 98.97	99.94	99.21	83.35	69.55
Interest Income/Expense	23.08% 0.02	0.026	0.025	0.026	0.019
Benefits Costs and Expenses	15.30% 105.95	91.89	110.08	92.73	82.00
Costs And Expenses	0.29% 110.13	109.82	110.08	92.73	82.00
Operating Income/Loss	2.62% -96.34	-98.93	-99.55	-81.72	-69.86
Nonoperating Income/Loss	123.72% 4.188	1.872	6.533	4.989	4.538
Income/Loss From Continuing Operations Before Tax	13.77% -92.15	-81.00	-99.55	-81.72	-69.86
Income Tax Expense/Benefit	80.82% -0.779	-4.062	-	-	-
Income/Loss From Continuing Operations After Tax	1.75% -91.37	-93.00	-93.02	-76.73	-65.33
Net Income/Loss	1.75% -91.37	-93.00	-93.02	-76.73	-65.33
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	4,855% 236.02	4.7631	214.33	201.42	191.62
Diluted Average Shares	4,855% 236.02	4.7631	214.33	201.42	191.62
Basic Earnings Per Share	7.14% -0.39	-0.42	-0.43	-0.38	-0.34
Diluted Earnings Per Share	7.14% -0.39	-0.42	-0.43	-0.38	-0.34
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-